E2F1 Has Both Oncogenic and Tumor-Suppressive Properties in a Transgenic Model

REFERENCES

• Bates, S., A. C. Phillips, P. A. Clark, F. Stott, G. Peters, R. L. Ludwig, and J. Vousden 1998. p14ARF links the tumour suppressors RB and p53. Nature 395:124–125 (Letter.)
   PubMed Web of Science ®Google Scholar
• Bianchi, A. B., S. M. Fischer, A. I. Robles, E. M. Rinchik, and J. Conti 1993. Overexpression of cyclin D1 in mouse skin carcinogenesis. Oncogene 8:1127–1133.
   PubMedGoogle Scholar
• Conti, C. J. 1994. The mouse skin as a model for chemical carcinogenesis, p. 39–46. In J. P. Sundberg (ed.), Handbook of mouse mutations with skin and hair abnormalities. CRC Press, Inc., Boca Raton, Fla.
   Google Scholar
• DeGregori, J., G. Leone, A. Miron, L. Jakoi, and J. Nevins 1997. Distinct roles for E2F proteins in cell growth control and apoptosis. Proc. Natl. Acad. Sci. USA 94:7245–7250.
   PubMed Web of Science ®Google Scholar
• Fueyo, J., C. Gomez-Manzano, W. K. A. Yung, T. J. Liu, R. Alemany, T. J. McDonnell, X. Shi, J. S. Rao, V. A. Levin, and J. Kyritsis 1998. Overexpression of E2F-1 in glioma triggers apoptosis and suppresses tumor growth in vitro and in vivo. Nat. Med. 4:685–690.
   PubMed Web of Science ®Google Scholar
• Gavrieli, Y., Y. Sherman, and J. Ben-Sasson 1992. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:493–501.
   PubMed Web of Science ®Google Scholar
• Hunt, K. K., J. Deng, T.-J. Liu, M. Wilson-Heiner, S. G. Swisher, G. Clayman, and J. Hung 1997. Adenovirus-mediated overexpression of the transcription factor E2F-1 induces apoptosis in human breast and ovarian carcinoma cell lines and does not require p53. Cancer Res. 57:4722–4726.
   PubMedGoogle Scholar
• Hupp, T. R., and J. Lane 1995. Two distinct signaling pathways activate the latent DNA binding function of p53 in a casein kinase II-independent manner. J. Biol. Chem. 270:18165–18174.
   PubMedGoogle Scholar
• Johnson, D. G., D. Cress, L. Jakoi, and J. Nevins 1994. Oncogenic capacity of the E2F1 gene. Proc. Natl. Acad. Sci. USA 91:12823–12827.
   PubMed Web of Science ®Google Scholar
• Kauffmann-Zeh, A., P. Rodriguez-Viciana, E. Ulrich, C. Gilbert, P. Coffer, J. Downward, and J. Evan 1997. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature 385:544–548.
   PubMed Web of Science ®Google Scholar
• Leder, A., A. Kuo, R. D. Cardiff, E. Sinn, and J. Leder 1990. v-Ha-ras transgene abrogates the initiation step in mouse skin tumorigenesis: effects of phorbol esters and retinoic acid. Proc. Natl. Acad. Sci. USA 87:9178–9182.
   PubMed Web of Science ®Google Scholar
• Marquardt, B., D. Fritch, and J. Stabel 1994. Signalling from TPA to MAP kinase requires protein kinase C, raf and MEK: reconstitution of the signalling pathway in vitro. Oncogene 9:3213–3218.
   PubMedGoogle Scholar
• Pan, H., C. Yin, N. J. Dyson, E. Harlow, L. Yamasaki, and J. Dyke 1998. Key roles for E2F1 in signaling p53-dependent apoptosis and in cell division within developing tumors. Mol. Cell 2:283–292.
   PubMed Web of Science ®Google Scholar
• Pena, J. C., C. M. Rudin, and J. Thompson 1998. A Bcl-XL transgene promotes malignant conversion of chemically initiated skin papillomas. Cancer Res. 58:2111–2116.
   PubMedGoogle Scholar
• Pierce, A. M., S. M. Fischer, C. J. Conti, and J. Johnson 1998. Deregulated expression of E2F1 induces hyperplasia and cooperates with ras in skin tumor development. Oncogene 16:1267–1276.
   PubMed Web of Science ®Google Scholar
• Pierce, A. M., I. B. Gimenez-Conti, R. Schneider-Broussard, L. A. Martinez, C. J. Conti, and J. Johnson 1998. Increased E2F1 activity induces skin tumors in mice heterozygous and nullizygous for p53. Proc. Natl. Acad. Sci. USA 95:8858–8863.
   PubMed Web of Science ®Google Scholar
• Quintanilla, M., K. Brown, M. Ramsden, and J. Balmain 1986. Carcinogen specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature 322:78–80.
   PubMed Web of Science ®Google Scholar
• Ramirez, A., A. Bravo, J. L. Jorcano, and J. Vida 1994. Sequences 5′ of the bovine keratin 5 gene direct tissue-and-cell-type-specific expression of a lacZ gene in the adult and during development. Differentiation 58:53–64.
   PubMed Web of Science ®Google Scholar
• Robles, A. I., and J. Conti 1995. Early overexpression of cyclin D1 in mouse skin carcinogenesis. Carcinogenesis 16:781–786.
   PubMedGoogle Scholar
• Rodriquez-Puebla, M. L., M. LaCava, I. B. Gimenez-Conti, D. J. Johnson, and J. Conti 1998. Deregulated expression of cell-cycle proteins during premalignant progression in SENCAR mouse skin. Oncogene 17:2251–2258.
   PubMedGoogle Scholar
• Sherr, C. J. 1996. Cancer cell cycles. Science 274:1672–1677.
   PubMed Web of Science ®Google Scholar
• Singh, P., S. Wong, and J. Hong 1994. Overexpression of E2F-1 in rat embryo fibroblasts leads to neoplastic transformation. EMBO J. 13:3329–3338.
   PubMed Web of Science ®Google Scholar
• Takenaka, I., F. Morin, B. R. Seizinger, and J. Kley 1995. Regulation of the sequence-specific DNA binding function of p53 by protein kinase C and protein phosphatases. J. Biol. Chem. 270:5405–5411.
   PubMed Web of Science ®Google Scholar
• Xu, G., D. M. Livingston, and J. Krek 1995. Multiple members of the E2F transcription factor family are the products of oncogenes. Proc. Natl. Acad. Sci. USA 92:1357–1361.
   PubMed Web of Science ®Google Scholar
• Yamasaki, L., T. Jacks, R. Bronson, E. Goillot, E. Harlow, and J. Dyson 1996. Tumor induction and tissue atrophy in mice lacking E2F-1. Cell 85:537–548.
   PubMed Web of Science ®Google Scholar
• Zhang, S.-Y., S.-C. Liu, T. Goodrow, R. Morris, and J. Klein-Szanto 1997. Increased expression of G1 cyclins and cyclin-dependent kinases during tumor progression of chemically induced mouse skin neoplasms. Mol. Carcinog. 18:142–152.
   PubMedGoogle Scholar